FX CorAL 40 (F00009214); FX CorAL 50 (F00009215)— 510(k) K242053

Name: FDA 510(k) clearance K242053
Creator: U.S. Food and Drug Administration
Published: 2025-03-21

Substantially Equivalent

Fresenius Medical Care Renal Therapies Group, LLC

FDA 510(k) clearance K242053 for FX CorAL 40 (F00009214); FX CorAL 50 (F00009215), Substantially Equivalent on 2025-03-21. Applicant: Fresenius Medical Care Renal Therapies Group, LLC. Device class: 2.

Clearance details

Applicant: Fresenius Medical Care Renal Therapies Group, LLC
Product code: Code KDI
Device class: Class 2
Regulation: 21 CFR 876.5860
Advisory panel: Gastroenterology, Urology
Date received: 2024-07-12
Decision date: 2025-03-21
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Waltham, MA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KDI

view all

K261267 — Careflux H60; Careflux H70; Careflux V5002026-07-24
K252377 — NxStage System One with NxView2026-05-15
K260533 — ELISIO-H2026-03-19
K252459 — multiFlux 130 (F00013123); multiFlux 160 (F00013124)2026-02-10
K253412 — Tablo Hemodialysis System (PN-0008000, PN-0006000U)2026-01-26

More clearances from Fresenius Medical Care Renal Therapies Group, LLC

view all

K253462 — NaturaLyte® Dry Bicarbonate Concentrate (08-4112-2)2026-01-29
K253518 — FX CorAL 40; FX CorAL 502025-12-18
K250634 — BCM2-Body Composition Monitor2025-11-24
K250471 — AquaC UNO H2025-11-14
K251851 — DIASAFEplusUS (F00013010)2025-10-09

Adverse events under product code KDI

product code KDI

Death: 352
Injury: 1,474
Malfunction: 12,534
Other: 4
Total: 14,364

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.